Newsworthy

Stormont Vail Health is bringing new hope to patients living with atrial fibrillation (AFib) by introducing the Affera™ Mapping and Ablation System with Sphere-9™ Catheter at Stormont Vail Hospital in Topeka. This advanced technology, recently approved by the U.S. Food and Drug Administration (FDA), represents a major step forward in heart care.

“This system allows us to treat AFib with greater precision and efficiency, all in one procedure,” said Dr. Alan Helmbold, Associate Physician, Vice President of Subspecialty Care Services. “It’s an exciting advancement that helps us deliver safer, more personalized care for our patients.”

The Affera system combines high-detail heart mapping with innovative energy therapies to correct irregular heart rhythms. By tailoring treatment to each patient’s needs, this technology offers a new level of care for those affected by AFib—a condition that impacts millions and can lead to serious health risks if untreated.

Stormont Vail is proud to be among the first to offer this breakthrough locally, giving patients access to the best heart care they deserve without having to travel far.

To learn more about Stormont Vail’s services, providers, and locations, visit stormontvail.org/heartcare. Patients with AFib may also ask for a consult with one of Stormont Vail’s cardiac electrophysiologists.